Grand River Expands Manufacturing Capacity
Grand River Aseptic Manufacturing, a parenteral contract development and manufacturing organization (CDMO), has made its second major equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN isolator.
The Bausch+Ströbel filler can fill 200 vials per minute and will more than triple Grand River's manufacturing capacity, maximizing flexibility in manufacturing solutions, increasing process efficiency and ensuring the highest level of sterility. The fully integrated fill line includes a vial washer, depyrogenation tunnel and filling machine and will fill vials ranging from 2mL to 50mL with 100% weight checks.
"GRAM continues to build our flexibility in the highly competitive CDMO market," said Nick Bykerk, vice president of business development and finance, Grand River. "Simultaneously, we are reinvesting in the development of our clinical-scale manufacturing. The combination of specialized clinical and commercial production with our analytical and development services offers a powerful solution to better meet the evolving needs of our clients."
The company is scheduling new projects starting in summer 2019. Tom Ross, president and chief executive officer of Grand River, said, "The fully integrated filling line is a significant capital investment capable of executing clients' complex parenteral manufacturing processes with the utmost precision. We look forward to serving our customers through additional investments in our facilities and finishing areas, including inspection, labeling and packaging."
Grand River's aggressive expansion plans also include the recent completion of a major land purchase agreement and the purchase of a new syringe filler.
"Grand River has always centered around quality and service, which has led to explosive growth," said Mr. Ross. "With Arlington Capital joining our company last November, we have the financial resources to invest in our customers through a planned expansion, new state-of-art injectable fill/finish equipment and additional highly trained staff."
To learn more about Grand River's parenteral capabilities, visit www.grandriverasepticmfg.com.
2026-09-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
CPHI & PMEC India 2026
-
8th Annual Pharma Manufacturing and Automation Convention 2026
-
Pharma Manufacturing & Automation Excellence Awards 2026
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Pharmaconex
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
Recommend Reading
-
ARLANXEO Launches State-of-the-Art HNBR Plant in Changzhou, Strengthening Asia-Pacific Supply
-
Death Toll from Fire at China-Russia Amur Polyolefins Project Rises to 15 as Construction Continues
-
South Korea to Impose Anti-Dumping Duties on Caustic Soda: Chinese Mainland Firms Face Up to 22.21%, Taiwan Region 38.89%
-
Chung Lien Oil’s 8,000-Ton Soybean Oil BaP Scandal: NT$165 Million Fine, 401 Product Recalls, Source Still Unknown
-
Kemira Acquires AquaBlue
-
Business Society’s Ethanol Market Outlook on September 2, 2026: Volatile Consolidation
-
Business Society’s Market Outlook for MIBK on August 27, 2026: Stable Operation
-
Business Society’s Market Outlook for Ethyl Acetate on September 2, 2026: Clearly Upward Trend
-
Business Society’s Market Outlook for Butadiene Rubber on August 26, 2026: Short-term Market Trends Primarily Characterized by Fluctuations
-
Business Society's Acetone Market View on September 1, 2026: Operating at High Levels